Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

M. Tokumasu, C. Murata, A. Shimada, K. Ohki, Y. Hayashi, A. M. Saito, J. Fujimoto, K. Horibe, M. Nagao, H. Itoh, Y. Kamikubo, H. Nakayama, A. Kinoshita, D. Tomizawa, T. Taga, A. Tawa, S. Tanaka, T. Heike, S. Adachi

Research output: Contribution to journalLetter

17 Citations (Scopus)
Original languageEnglish
Pages (from-to)2438-2441
Number of pages4
JournalLeukemia
Volume29
Issue number12
DOIs
Publication statusPublished - Dec 1 2015

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Tokumasu, M., Murata, C., Shimada, A., Ohki, K., Hayashi, Y., Saito, A. M., Fujimoto, J., Horibe, K., Nagao, M., Itoh, H., Kamikubo, Y., Nakayama, H., Kinoshita, A., Tomizawa, D., Taga, T., Tawa, A., Tanaka, S., Heike, T., & Adachi, S. (2015). Adverse prognostic impact of KIT mutations in childhood CBF-AML: The results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Leukemia, 29(12), 2438-2441. https://doi.org/10.1038/leu.2015.121